Pesquisas alternativas:
loss develop » locus develop (Expandir a Pesquisa), boys develop (Expandir a Pesquisa), less developed (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa)
drug loss » drug lots (Expandir a Pesquisa), drug cross (Expandir a Pesquisa), drug lists (Expandir a Pesquisa)
de devel » de deber (Expandir a Pesquisa), de devic (Expandir a Pesquisa), _ devel (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
loss develop » locus develop (Expandir a Pesquisa), boys develop (Expandir a Pesquisa), less developed (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa)
drug loss » drug lots (Expandir a Pesquisa), drug cross (Expandir a Pesquisa), drug lists (Expandir a Pesquisa)
de devel » de deber (Expandir a Pesquisa), de devic (Expandir a Pesquisa), _ devel (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
81
“... validation set than the most rigorous strategy developed by drug experts with no loss of accuracy. The best...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
82
Por Shah, Syed Muhammad Hassan, Ullah, Farhat, Khan, Shahzeb, Shah, Syed Muhammad Mukarram, de Matas, Marcel, Hussain, Zahid, Minhas, Muhammad Usman, AbdEl-Salam, Naser M, Assi, Khaled Hafez, Isreb, Mohammad
Publicado no Drug Des Devel Ther (2016)
“...Artemether (ARTM) is a very effective antimalarial drug with poor solubility and consequently low...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
83
“... types of single-agent drugs are in late stage development, including (1) selective central cannabinoid-1...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
84
“...-drug RT abolished the elevated strand transfer activity and RNase H activity in addition to the loss...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
85
Por Berman, Ari E., Chan, Wai Yee, Brennan, Angela M., Reyes, Reno C., Adler, Brittany L., Suh, Sang Won, Kauppinen, Tiina M., Edling, Ylva, Swanson, Raymond A.
Publicado em 2010
“...-drug, as a potential disease-modifying intervention for PD. METHODS: Wild-type mice, EAAC1(−/−) mice...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
86
CS-886, a new angiotensin II type 1 receptor antagonist, ameliorates glomerular anionic site loss...
Por Koga, Kohachiro, Yamagishi, Sho-ichi, Takeuchi, Masayoshi, Inagaki, Yosuke, Amano, Shinjiro, Okamoto, Tamami, Saga, Tsuyoshi, Makita, Zenji, Yoshizuka, Mitsuaki
Publicado em 2002
“... compared the effects of CS-866, a new angiotensin II type 1 receptor antagonist, to that of an ACE...”Publicado em 2002
Obter o texto integral
Obter o texto integral
Artigo
87
Por Lecka-Czernik, Beata
Publicado em 2010
“... of fractures. One class of antidiabetic drugs, thiazolidinediones (TZDs), causes bone loss and further...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
88
Por Martí Colom-Cadena, Tara Spires-Jones, Henrik Zetterberg, Kaj Blennow, Anthony Caggiano, Steven T. DeKosky, Howard Fillit, John E. Harrison, Lon S. Schneider, Phillip Scheltens, Willem de Haan, Michael Grundman, Christopher H. van Dyck, Nicholas J. Izzo, Susan M. Catalano, the Synaptic Health Endpoints Working Group
Publicado em 2020-03-01
“... that measure synapse degeneration or loss in patients will facilitate clinical development of such drugs...”Publicado em 2020-03-01
Obter o texto integral
Artigo
89
“.... This review presents latest developments of SB in the field of drug discovery, including some challenging...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
90
Por Abukhdeir, Abde M., Vitolo, Michele I., Argani, Pedram, De Marzo, Angelo M., Karakas, Bedri, Konishi, Hiroyuki, Gustin, John P., Lauring, Josh, Garay, Joseph P., Pendleton, Courtney, Konishi, Yuko, Blair, Brian G., Brenner, Keith, Garrett-Mayer, Elizabeth, Carraway, Hetty, Bachman, Kurtis E., Park, Ben Ho
Publicado em 2008
“... resistant breast cancers develop a growth proliferative response to this drug, as evidenced by tumor...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
91
Por Khivia Kiss Silva Barbosa, Walkiria da Silva Rocha, Kay Francis Leal Vieira, Estela Rodrigues Paiva Alves, Gerlaine de Oliveira Leite, Maria Djair Dias
Publicado em 2015-07-01
“...Revista de Enfermagem da Universidade Federal de Santa Maria...”Publicado em 2015-07-01
Obter o texto integral
Artigo
92
93
“... developed for inner ear drug delivery, including micropump-based devices, reciprocating systems...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
94
“... by abdominal pain, bloating
and diarrhoea. Adult-type hypolactasia is the most common cause of lactose...”
Obter o texto integral
Obter o texto integral
Artigo
95
Por A. L. Poznyak, S. S. Kozlov, R. V. Gudkov, Yu. F. Zaharkiv, S. N. Sidorchuk, O. L. Molchanov
Publicado em 2014-09-01
“... of their enzyme systems, generating and transporting electrons, which can then transfer them to the nitro group...”Publicado em 2014-09-01
Obter o texto integral
Artigo
96
“... and survival. The genetic loss of NF2 (neurofibromatosis type 2) leading to increased cell proliferation...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
97
Por Zanders, Edward D.
Publicado em 2011
“... the jargon used in drug development, but in a way that avoids over simplification and the resulting loss...”Publicado em 2011
Obter o texto integral
Livro
98
99
Por Fernández-Fernández, Cristina, Callado, Luis F, Girón, Rocío, Sánchez, Eva, Erdozain, Amaia M, López-Moreno, José Antonio, Morales, Paula, Rodríguez de Fonseca, Fernando, Fernández-Ruiz, Javier, Goya, Pilar, Meana, J Javier, Martín, M Isabel, Jagerovic, Nadine
Publicado em 2014
“... has been prepared by coupling the molecular features of two wellknown drugs, ie, rimonabant...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
100
Por Liu, Zhenyi, Turkoz, Ahu, Jackson, Erin N., Corbo, Joseph C., Engelbach, John A., Garbow, Joel R., Piwnica-Worms, David R., Kopan, Raphael
Publicado em 2011
“.... Through this approach, we determined the cell types most affected by Notch1 loss. We report that the loss...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo